Anushka Naidoo

Durban, ZN, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Survival in sight: Rethinking PDE5 inhibitors in ILD-associated pulmonary hypertension.

Survival in sight: Rethinking PDE5 inhibitors in ILD-associated pulmonary hypertension.

Journal: African journal of thoracic and critical care medicine

Published: February 13, 2026

Pharmacokinetics of Twice-daily Tenofovir Alafenamide in Adults With HIV-associated Tuberculosis on Bictegravir/Emtricitabine/Tenofovir Alafenamide and Rifampicin.

Pharmacokinetics of Twice-daily Tenofovir Alafenamide in Adults With HIV-associated Tuberculosis on Bictegravir/Emtricitabine/Tenofovir Alafenamide and Rifampicin.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: September 05, 2025

Pharmacokinetic modelling as a tool to assess TB treatment adherence: application to the REMEMBER study.

Pharmacokinetic modelling as a tool to assess TB treatment adherence: application to the REMEMBER study.

Journal: IJTLD open

Published: July 22, 2025

Fixed-dose combination bictegravir-emtricitabine-tenofovir alafenamide twice-daily for treatment of HIV during rifampicin-based tuberculosis treatment (INSIGHT Study): a phase 2b, open-label, randomised non-comparative trial.

Fixed-dose combination bictegravir-emtricitabine-tenofovir alafenamide twice-daily for treatment of HIV during rifampicin-based tuberculosis treatment (INSIGHT Study): a phase 2b, open-label, randomised non-comparative trial.

Journal: The lancet. HIV

Published: April 16, 2025

Feasibility and acceptability of GeneXpert MTB/XDR implementation among healthcare workers in three low-middle income African countries.

Feasibility and acceptability of GeneXpert MTB/XDR implementation among healthcare workers in three low-middle income African countries.

Journal: PloS one

Published: January 24, 2025

Triage test for all-oral drug-resistant tuberculosis (DR-TB) regimen: a phase IV study to assess effectiveness, feasibility, acceptability and cost-effectiveness of the Xpert MTB/XDR assay for rapid triage and treatment of DR-TB.

Triage test for all-oral drug-resistant tuberculosis (DR-TB) regimen: a phase IV study to assess effectiveness, feasibility, acceptability and cost-effectiveness of the Xpert MTB/XDR assay for rapid triage and treatment of DR-TB.

Journal: BMJ open

Published: November 28, 2024

Pharmacokinetics and safety of dolutegravir in children receiving rifampicin tuberculosis treatment in South Africa (ORCHID): a prospective cohort study.

Pharmacokinetics and safety of dolutegravir in children receiving rifampicin tuberculosis treatment in South Africa (ORCHID): a prospective cohort study.

Journal: The lancet. HIV

Published: June 21, 2024

The utility of brain natriuretic peptide as a prognosticating marker in critical care patients.

The utility of brain natriuretic peptide as a prognosticating marker in critical care patients.

Journal: The Southern African journal of critical care : the official journal of the Critical Care Society

Published: October 16, 2023

Polymorphisms within the SARS-CoV-2 Human Receptor Genes Associate with Variable Disease Outcomes across Ethnicities.

Polymorphisms within the SARS-CoV-2 Human Receptor Genes Associate with Variable Disease Outcomes across Ethnicities.

Journal: Genes

Published: August 24, 2023

Broadening access to tenofovir alafenamide for the treatment and prevention of HIV-1 infection.

Broadening access to tenofovir alafenamide for the treatment and prevention of HIV-1 infection.

Journal: Expert review of clinical pharmacology

Published: August 23, 2023

Dolutegravir once daily with rifampicin for HIV and tuberculosis.

Dolutegravir once daily with rifampicin for HIV and tuberculosis.

Journal: The lancet. HIV

Published: April 21, 2023

Clinical impact of plasma concentrations of first-line antituberculosis drugs.

Clinical impact of plasma concentrations of first-line antituberculosis drugs.

Journal: South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde

Published: March 02, 2023

Showing 1-12 of 36

Last Updated: 09/26/2026